GeneTex
  • Country / Location Selection

United States (US)

West Nile virus Capsid peptide

Cat No. GTX85510-PEP

Application

Neutralizing/Inhibition

Species

West Nile virus
Package
50 μg ($139)

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH7.2, 10mM NaH₂PO₄, 10mM Na₂HPO₄, 130mM NaCl, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store the peptide at -20ºC, stable for one year.

Concentration

0.20 mg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

West Nile virus Capsid protein , WNV Capsid protein , West Nile virus Core , WNV Core

Background

West Nile virus peptide is used for blocking the activity of West Nile Virus Core Protein antibody (Cat. No. GTX85510). It usually blocks the West Nile Virus antibody activity completely in ELISA by incubating the peptide with equal volume of antibody for 30 min at 37oC.

Research Area

REFERENCE

There are currently no references for West Nile virus Capsid peptide (GTX85510-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for West Nile virus Capsid peptide (GTX85510-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139